D
Deepa Naishadham
Researcher at American Cancer Society
Publications - 29
Citations - 25644
Deepa Naishadham is an academic researcher from American Cancer Society. The author has contributed to research in topics: Hepatitis C & Ribavirin. The author has an hindex of 22, co-authored 29 publications receiving 24704 citations.
Papers
More filters
Journal ArticleDOI
Cancer statistics, 2013
TL;DR: Overall cancer death rates have declined 20% from their peak in 1991 to 2009 and can be accelerated by applying existing cancer control knowledge across all segments of the population, with an emphasis on those groups in the lowest socioeconomic bracket and other underserved populations.
Journal ArticleDOI
Cancer statistics, 2012
TL;DR: The reduction in overall cancer death rates since 1990 in men and 1991 in women translates to the avoidance of about 1,024,400 deaths from cancer, which can be accelerated by applying existing cancer control knowledge across all segments of the population, with an emphasis on those groups in the lowest socioeconomic bracket.
Journal ArticleDOI
Experiences of discrimination: Validity and reliability of a self-report measure for population health research on racism and health
TL;DR: The results underscore the need for using validated, multi-item measures of experiences of racial discrimination and suggest the EOD may be one such measure that can be validly employed with working class African Americans and Latino Americans.
Journal ArticleDOI
Cancer Statistics for Hispanics/Latinos, 2012
TL;DR: Hispanics/Latinos are the largest and fastest growing major demographic group in the United States, accounting for 16.3% (50.5 million/310 million) of the US population in 2010 and have lower incidence and death rates than non‐Hispanic whites for all cancers combined and for the 4 most common cancers.
Journal ArticleDOI
Cancer statistics for African Americans, 2013
TL;DR: Overall, progress in reducing cancer death rates has been made, although more can and should be done to accelerate this progress through ensuring equitable access to cancer prevention, early detection, and state-of-the-art treatments.